Cargando…

Isoniazid-induced Immune Thrombocytopenia

Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwabara, Gaku, Tazoe, Kumiyo, Imoto, Waki, Yamairi, Kazushi, Shibata, Wataru, Oshima, Kazuhiro, Yamada, Koichi, Takagi, Yasuhiro, Shiraishi, Satoshi, Hino, Masayuki, Kawaguchi, Tomoya, Kakeya, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666230/
https://www.ncbi.nlm.nih.gov/pubmed/34053983
http://dx.doi.org/10.2169/internalmedicine.6520-20
_version_ 1784614162583781376
author Kuwabara, Gaku
Tazoe, Kumiyo
Imoto, Waki
Yamairi, Kazushi
Shibata, Wataru
Oshima, Kazuhiro
Yamada, Koichi
Takagi, Yasuhiro
Shiraishi, Satoshi
Hino, Masayuki
Kawaguchi, Tomoya
Kakeya, Hiroshi
author_facet Kuwabara, Gaku
Tazoe, Kumiyo
Imoto, Waki
Yamairi, Kazushi
Shibata, Wataru
Oshima, Kazuhiro
Yamada, Koichi
Takagi, Yasuhiro
Shiraishi, Satoshi
Hino, Masayuki
Kawaguchi, Tomoya
Kakeya, Hiroshi
author_sort Kuwabara, Gaku
collection PubMed
description Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who developed thrombocytopenia during tuberculosis treatment. Platelet-associated immunoglobulin G and a drug-induced lymphocyte stimulation test for isoniazid were positive; no other causes of thrombocytopenia were identified. The patient was diagnosed with isoniazid-induced immune thrombocytopenia, and the platelet count normalized after isoniazid discontinuation. We describe the immunological mechanism of thrombocytosis due to isoniazid, an uncommon cause of thrombocytopenia that physicians should be aware exists.
format Online
Article
Text
id pubmed-8666230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-86662302021-12-28 Isoniazid-induced Immune Thrombocytopenia Kuwabara, Gaku Tazoe, Kumiyo Imoto, Waki Yamairi, Kazushi Shibata, Wataru Oshima, Kazuhiro Yamada, Koichi Takagi, Yasuhiro Shiraishi, Satoshi Hino, Masayuki Kawaguchi, Tomoya Kakeya, Hiroshi Intern Med Case Report Drug-induced thrombocytopenia occurs through immune-mediated platelet destruction, and its management is challenging during tuberculosis treatment. Although rifampicin is the most common drug causing thrombocytopenia, isoniazid can also cause thrombocytopenia. We herein report a 75-year-old man who developed thrombocytopenia during tuberculosis treatment. Platelet-associated immunoglobulin G and a drug-induced lymphocyte stimulation test for isoniazid were positive; no other causes of thrombocytopenia were identified. The patient was diagnosed with isoniazid-induced immune thrombocytopenia, and the platelet count normalized after isoniazid discontinuation. We describe the immunological mechanism of thrombocytosis due to isoniazid, an uncommon cause of thrombocytopenia that physicians should be aware exists. The Japanese Society of Internal Medicine 2021-05-29 2021-11-15 /pmc/articles/PMC8666230/ /pubmed/34053983 http://dx.doi.org/10.2169/internalmedicine.6520-20 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kuwabara, Gaku
Tazoe, Kumiyo
Imoto, Waki
Yamairi, Kazushi
Shibata, Wataru
Oshima, Kazuhiro
Yamada, Koichi
Takagi, Yasuhiro
Shiraishi, Satoshi
Hino, Masayuki
Kawaguchi, Tomoya
Kakeya, Hiroshi
Isoniazid-induced Immune Thrombocytopenia
title Isoniazid-induced Immune Thrombocytopenia
title_full Isoniazid-induced Immune Thrombocytopenia
title_fullStr Isoniazid-induced Immune Thrombocytopenia
title_full_unstemmed Isoniazid-induced Immune Thrombocytopenia
title_short Isoniazid-induced Immune Thrombocytopenia
title_sort isoniazid-induced immune thrombocytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666230/
https://www.ncbi.nlm.nih.gov/pubmed/34053983
http://dx.doi.org/10.2169/internalmedicine.6520-20
work_keys_str_mv AT kuwabaragaku isoniazidinducedimmunethrombocytopenia
AT tazoekumiyo isoniazidinducedimmunethrombocytopenia
AT imotowaki isoniazidinducedimmunethrombocytopenia
AT yamairikazushi isoniazidinducedimmunethrombocytopenia
AT shibatawataru isoniazidinducedimmunethrombocytopenia
AT oshimakazuhiro isoniazidinducedimmunethrombocytopenia
AT yamadakoichi isoniazidinducedimmunethrombocytopenia
AT takagiyasuhiro isoniazidinducedimmunethrombocytopenia
AT shiraishisatoshi isoniazidinducedimmunethrombocytopenia
AT hinomasayuki isoniazidinducedimmunethrombocytopenia
AT kawaguchitomoya isoniazidinducedimmunethrombocytopenia
AT kakeyahiroshi isoniazidinducedimmunethrombocytopenia